cbd hemp meds

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

According to a recent report by Grand View Research, the global CBD gummies market size was valued at USD 1.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 30.7% from 2021 to 2028.

To learn more about HempMeds® or purchase these products, please visit www.hempmedspx.com.

Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.

SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has released a brand new product to complement its extensive product line, broad-spectrum cannabidiol (CBD)-infused gummies.

“As the cannabis industry evolves, so do the buying habits of our consumers and we want to be able to meet all of their needs,” said HempMeds® CEO Raul Elizalde. “We have always prioritized the feedback of our customers and we feel that these gummies are the next best addition to our growing line of Triple Lab Tested hemp-derived CBD products.”

See also  holiday inn perth cbd

About HempMeds®
Founded in 2012, HempMeds® was the first company to bring hemp-based cannabidiol (CBD) oil products to market in the U.S., Brazil and Mexico. As a subsidiary of Medical Marijuana, Inc., HempMeds® is the exclusive distributor for premium brands such as Real Scientific Hemp Oil™. The Company operates in all 50 states and throughout Latin America in countries such as Mexico, Brazil, Argentina, Paraguay and more. HempMeds® is one of the only companies to have its CBD products listed in the Prescribers’ Digital Reference (PDR), the only company invited to speak to the World Health Organization and FDA on the benefits of CBD, and one of the first to be certified by the U.S. Hemp Authority. To learn more, please visit www.hempmedspx.com.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

July 22, 2021 09:00 ET | Source: Medical Marijuana, Inc. Medical Marijuana, Inc.

Cbd hemp meds

“The popularity of CBD gummies has grown over the past year and doesn’t seem to be slowing down,” Elizalde said. “We’ve crafted ours with the highest standards of safety and quality and instead of making them with CBD isolate like many of our competitors, we’ve made them with high-quality broad-spectrum CBD.”

HempMeds gummies are gluten-free, vegan, and come in three flavors: Lime, Strawberry and Orange. Each jar contains 1,200 mg CBD, broken down into 60 20-mg pieces. These gummies contain a proprietary blend of hemp oil, as well as natural fruit flavor ingredients.

See also  trokie cbd patch

“As the cannabis industry evolves, so do the buying habits of our consumers and we want to be able to meet all of their needs,” said HempMeds CEO Raul Elizalde. “We have always prioritized the feedback of our customers and we feel that these gummies are the next best addition to our growing line of Triple Lab Tested hemp-derived CBD products.”

According to a recent report by Grand View Research, the global CBD gummies market size was valued at $1.6 billion in 2020 and is expected to expand at a compound annual growth rate 30.7% from 2021 to 2028.

Medical Marijuana, Inc.’s subsidiary HempMeds has introduced broad-spectrum CBD-infused gummies.

Want more legal cannabis market news and information?
Join Cannabis Products on Facebook, Twitter, and LinkedIn today!